Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1983 Nov;80(3):533–543. doi: 10.1111/j.1476-5381.1983.tb10726.x

Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats.

J L Freslon, J F Giudicelli
PMCID: PMC2045007  PMID: 6357337

Abstract

When administered to young spontaneously hypertensive rats (SHRs), dihydralazine (25 mg kg-1, daily) and captopril (100 mg kg-1, daily) prevent with the same efficacy genetic hypertension development (GHD). Dihydralazine treatment increased vascular mesenteric compliance, as shown by a significant decrease in the stiffness of the vessels (-27%), and induced slight reductions in contractility (-12%) and in wall to lumen (W/L) ratio (-15%). After treatment withdrawal, all these parameters returned to control values within 7 weeks, as did blood pressure. Captopril treatment also strongly increased the mesenteric vessels compliance, vessel stiffness being decreased by 16%, and reduced their contractility (-15%) and their W/L ratio (-30%). These effects as well as those exerted on blood pressure persisted up to 7 weeks after treatment ceased although there was a slight trend to a progressive reduction in the intensity of both phenomena. These experiments show that captopril but not dihydralazine has a long-lasting effect in opposing the functional and morphological vascular alterations occurring during GHD in SHRs and this phenomenon probably contributes to a large extent to the sustained preventive effects of the drug against GHD.

Full text

PDF
533

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antonaccio M. J., Rubin B., Horovitz Z. P., Laffan R. J., Goldberg M. E., High J. P., Harris D. N., Zaidi I. Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats. Jpn J Pharmacol. 1979 Apr;29(2):285–294. doi: 10.1254/jjp.29.285. [DOI] [PubMed] [Google Scholar]
  2. Antonaccio M. J., Rubin B., Kotler D. Effects of captopril on vascular reactivity of SHR in vivo and in vitro. Hypertension. 1981 Nov-Dec;3(6 Pt 2):II–211-5. doi: 10.1161/01.hyp.3.6_pt_2.ii-211. [DOI] [PubMed] [Google Scholar]
  3. Asaad M. M., Antonaccio M. J. Vascular wall renin in spontaneously hypertensive rats. Potential relevance to hypertension maintenance and antihypertensive effect of captopril. Hypertension. 1982 Jul-Aug;4(4):487–493. doi: 10.1161/01.hyp.4.4.487. [DOI] [PubMed] [Google Scholar]
  4. Bianchi G., Fox U., Imbasciati E. The development of a new strain of spontaneously hypertensive rats. Life Sci. 1974 Jan 16;14(2):339–347. doi: 10.1016/0024-3205(74)90064-2. [DOI] [PubMed] [Google Scholar]
  5. Casellas D., Mimran A., Dupont M., Chevillard C. Attenuation by SQ 14,255 (captopril) of the vascular response to noradrenaline in the rate isolated kidney. Br J Clin Pharmacol. 1980 Dec;10(6):621–623. doi: 10.1111/j.1365-2125.1980.tb00521.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cohen M. L., Kurz K. D. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421. J Pharmacol Exp Ther. 1982 Jan;220(1):63–69. [PubMed] [Google Scholar]
  7. Collis M. G., Keddie J. R. Captopril attenuates adrenergic vasoconstriction in rat mesenteric arteries by angiotensin-dependent and -independent mechanisms. Clin Sci (Lond) 1981 Sep;61(3):281–286. doi: 10.1042/cs0610281. [DOI] [PubMed] [Google Scholar]
  8. FURUYAMA M. Histometrical investigations of arteries in reference to arterial hypertension. Tohoku J Exp Med. 1962 May 25;76:388–414. doi: 10.1620/tjem.76.388. [DOI] [PubMed] [Google Scholar]
  9. Ferrone R. A., Antonaccio M. J. Prevention of the development of spontaneous hypertension in rats by captopril (SQ 14,225). Eur J Pharmacol. 1979 Dec 7;60(2-3):131–137. doi: 10.1016/0014-2999(79)90211-5. [DOI] [PubMed] [Google Scholar]
  10. Ferrone R. A., Heran C. L., Antonaccio M. J. Comparison of the acute and chronic hemodynamic effects of captopril and guanethidine in spontaneously hypertensive rats. Clin Exp Hypertens. 1980 Feb;2(2):247–272. doi: 10.3109/10641968009046423. [DOI] [PubMed] [Google Scholar]
  11. Folkow B., Hallbäck M., Lundgren Y., Sivertsson R., Weiss L. Importance of adaptive changes in vascular design for establishment of primary hypertension, studied in man and in spontaneously hypertensive rats. Circ Res. 1973 May 5;32(Suppl):2–16. doi: 10.1007/978-3-642-65441-1_23. [DOI] [PubMed] [Google Scholar]
  12. Frohlich E. D., Tarazi R. C. Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol. 1979 Oct 22;44(5):959–963. doi: 10.1016/0002-9149(79)90229-7. [DOI] [PubMed] [Google Scholar]
  13. GOULD A. B., SKEGGS L. T., Jr, KAHN J. R. THE PRESENCE OF RENIN ACTIVITY IN BLOOD VESSEL WALLS. J Exp Med. 1964 Mar 1;119:389–399. doi: 10.1084/jem.119.3.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Garst J. B., Koletsky S., Wisenbaugh P. E., Hadady M., Matthews D. Arterial wall renin and renal venous renin in the hypertensive rat. Clin Sci (Lond) 1979 Jan;56(1):41–46. doi: 10.1042/cs0560041. [DOI] [PubMed] [Google Scholar]
  15. Giudicelli J. F., Freslon J. L., Glasson S., Richer C. Captopril and hypertension development in the SHR. Clin Exp Hypertens. 1980;2(6):1083–1096. doi: 10.3109/10641968009037162. [DOI] [PubMed] [Google Scholar]
  16. Greeberg S. Studies on the effect of chronic oral administration of minoxidil and hydralazine on vascular function in spontaneously hypertensive rats. J Pharmacol Exp Ther. 1980 Nov;215(2):279–286. [PubMed] [Google Scholar]
  17. Halpern W., Mulvany M. J., Warshaw D. M. Mechanical properties of smooth muscle cells in the walls of arterial resistance vessels. J Physiol. 1978 Feb;275:85–101. doi: 10.1113/jphysiol.1978.sp012179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hamilton T. C. Influence of anti-hypertensive drug treatment on vascular reactivity in spontaneously hypertensive rats. Br J Pharmacol. 1975 Aug;54(4):429–436. doi: 10.1111/j.1476-5381.1975.tb07588.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hart M. N., Heistad D. D., Brody M. J. Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels. Hypertension. 1980 Jul-Aug;2(4):419–423. doi: 10.1161/01.hyp.2.4.419. [DOI] [PubMed] [Google Scholar]
  20. Ichijima K. Morphological studies on the peripheral small arteries of spontaneously hypertensive rats. Jpn Circ J. 1969 Aug;33(8):785–813. doi: 10.1253/jcj.33.785. [DOI] [PubMed] [Google Scholar]
  21. Kikta D. C., Fregly M. J. Effect of in vitro administration of captopril on vascular reactivity of rat aorta. Hypertension. 1982 Jan-Feb;4(1):118–124. doi: 10.1161/01.hyp.4.1.118. [DOI] [PubMed] [Google Scholar]
  22. Koike H., Ito K., Miyamoto M., Nishino H. Effects of long-term blockade of angiotensin converting enzyme with captopril (SQ14,225) on hemodynamics and circulating blood volume in SHR. Hypertension. 1980 May-Jun;2(3):299–303. doi: 10.1161/01.hyp.2.3.299. [DOI] [PubMed] [Google Scholar]
  23. Malik K. U., Nasjletti A. Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries. Circ Res. 1976 Jan;38(1):26–30. doi: 10.1161/01.res.38.1.26. [DOI] [PubMed] [Google Scholar]
  24. Mulvany M. J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977 Jul;41(1):19–26. doi: 10.1161/01.res.41.1.19. [DOI] [PubMed] [Google Scholar]
  25. Mulvany M. J., Halpern W. Mechanical properties of vascular smooth muscle cells in situ. Nature. 1976 Apr 15;260(5552):617–619. doi: 10.1038/260617a0. [DOI] [PubMed] [Google Scholar]
  26. Mulvany M. J., Hansen O. K., Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res. 1978 Dec;43(6):854–864. doi: 10.1161/01.res.43.6.854. [DOI] [PubMed] [Google Scholar]
  27. Mulvany M. J., Warshaw D. M. The active tension-length curve of vascular smooth muscle related to its cellular components. J Gen Physiol. 1979 Jul;74(1):85–104. doi: 10.1085/jgp.74.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Okuno T., Kondo K., Konishi K., Saruta T., Kato E. SQ 14,225 attenuates the vascular response to norepinephrine in the rat mesenteric arteries. Life Sci. 1979 Oct 8;25(15):1343–1349. doi: 10.1016/0024-3205(79)90401-6. [DOI] [PubMed] [Google Scholar]
  29. Pettinger W. A., Campbell W. B., Keeton K. Adrenergic component of renin release induced by vasodilating antihypertensive drugs in the rat. Circ Res. 1973 Jul;33(1):82–86. doi: 10.1161/01.res.33.1.82. [DOI] [PubMed] [Google Scholar]
  30. ROACH M. R., BURTON A. C. The reason for the shape of the distensibility curves of arteries. Can J Biochem Physiol. 1957 Aug;35(8):681–690. [PubMed] [Google Scholar]
  31. Re R., Fallon J. T., Dzau V., Quay S. C., Haber E. Renin synthesis by canine aortic smooth muscle cells in culture. Life Sci. 1982 Jan 4;30(1):99–106. doi: 10.1016/0024-3205(82)90641-5. [DOI] [PubMed] [Google Scholar]
  32. Seidel C. L., Allen J. C., Bowers R. L. Mechanical and biochemical alterations of aorta induced by hydralazine hypotension. J Pharmacol Exp Ther. 1980 Jun;213(3):514–519. [PubMed] [Google Scholar]
  33. Sen S., Tarazi R. C., Bumpus F. M. Cardiac hypertrophy and antihypertensive therapy. Cardiovasc Res. 1977 Sep;11(5):427–433. doi: 10.1093/cvr/11.5.427. [DOI] [PubMed] [Google Scholar]
  34. Sen S., Tarazi R. C., Bumpus F. M. Effect of converting enzyme inhibitor (SQ14,225) on myocardial hypertrophy in spontaneously hypertensive rats. Hypertension. 1980 Mar-Apr;2(2):169–176. doi: 10.1161/01.hyp.2.2.169. [DOI] [PubMed] [Google Scholar]
  35. Sen S., Tarazi R. C., Khairallah P. A., Bumpus F. M. Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res. 1974 Nov;35(5):775–781. doi: 10.1161/01.res.35.5.775. [DOI] [PubMed] [Google Scholar]
  36. Sinaiko A. R. Influence of adrenergic nervous system on vasodilator-induced renin release in the conscious rat. Proc Soc Exp Biol Med. 1981 May;167(1):25–29. doi: 10.3181/00379727-167-41119. [DOI] [PubMed] [Google Scholar]
  37. Spertini F., Brunner H. R., Waeber B., Gavras H. The opposing effects of chronic angiotensin-converting enzyme blockade by captopril on the responses to exogenous angiotensin II and vasopressin vs. norepinephrine in rats. Circ Res. 1981 May;48(5):612–618. doi: 10.1161/01.res.48.5.612. [DOI] [PubMed] [Google Scholar]
  38. Swales J. D. Arterial wall or plasma renin in hypertension? Clin Sci (Lond) 1979 Apr;56(4):293–298. doi: 10.1042/cs0560293. [DOI] [PubMed] [Google Scholar]
  39. Thurston H., Swales J. D., Bing R. F., Hurst B. C., Marks E. S. Vascular renin-like activity and blood pressure maintenance in the rat. Studies of the effect of changes in sodium balance, hypertension and nephrectomy. Hypertension. 1979 Nov-Dec;1(6):643–649. doi: 10.1161/01.hyp.1.6.643. [DOI] [PubMed] [Google Scholar]
  40. Tobia A. J., Lee J. Y., Walsh G. M. Regional blood flow and vascular resistance in the spontaneously hypertensive rat. Cardiovasc Res. 1974 Nov;8(6):758–762. doi: 10.1093/cvr/8.6.758. [DOI] [PubMed] [Google Scholar]
  41. Ueda H., Yagi S., Kaneko Y. Hydralazine and plasma renin activity. Arch Intern Med. 1968 Nov;122(5):387–391. [PubMed] [Google Scholar]
  42. Unger T., Yukimura T., Marin-Grez M., Lang R. E., Rascher W., Ganten D. SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats. Eur J Pharmacol. 1982 Mar 26;78(4):411–420. doi: 10.1016/0014-2999(82)90483-6. [DOI] [PubMed] [Google Scholar]
  43. Velletri P., Bean B. L. The effects of captopril on rat aortic angiotensin-converting enzyme. J Cardiovasc Pharmacol. 1982 Mar-Apr;4(2):315–325. doi: 10.1097/00005344-198203000-00022. [DOI] [PubMed] [Google Scholar]
  44. Yamori Y., Nakada T., Lovenberg W. Effect of antihypertensive therapy on lysine incorporation into vascular protein of the spontaneously hypertensive rat. Eur J Pharmacol. 1976 Aug;38(2):349–355. doi: 10.1016/0014-2999(76)90339-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES